Advanced search
Publication Cover
Cutaneous and Ocular Toxicology Volume 35, 2016 - Issue 4
Submit an article Journal homepage
199
Views
6
CrossRef citations to date
0
Altmetric
Case Report

Vemurafenib-induced pityriasis amiantacea: a case report

Özlem BilgiçDepartment of Dermatology, Faculty of Medicine, Selcuk University, Konya, TurkeyCorrespondence[email protected]
Pages 329-331 | Received 17 Aug 2015, Accepted 21 Sep 2015, Published online: 29 Oct 2015

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Peng Chen, Fucaho Chen & Benhong Zhou. (2019) The risk of dermatological toxicities of combined BRAF and MEK inhibition versus BRAF inhibition alone in melanoma patients: a systematic review and meta-analysis. Cutaneous and Ocular Toxicology 38:2, pages 105-111.
Read now

Articles from other publishers (5)

Albert G. Wu, Steven Barilla & Raman K. Madan. (2022) Manifestation of pityriasis amiantacea following initiation of minoxidil. JAAD Case Reports 24, pages 94-96.
Crossref
Hyun-Bin Kwak, Seok-Kweon Yun, Han-Uk Kim & Jin Park. (2020) Pityriasis Amiantacea: An Epidemiologic Study of 44 Cases in Korean Patients. Annals of Dermatology 32:1, pages 83.
Crossref
J.F. Mir-Bonafé, D. Saceda-Corralo & S. Vañó-Galván. (2019) Adverse Hair Reactions to New Targeted Therapies for Cancer. Actas Dermo-Sifiliográficas (English Edition) 110:3, pages 182-192.
Crossref
J.F. Mir-Bonafé, D. Saceda-Corralo & S. Vañó-Galván. (2019) Reacciones capilares de las nuevas terapias diana dirigidas contra el cáncer. Actas Dermo-Sifiliográficas 110:3, pages 182-192.
Crossref
. (2016) Vemurafenib. Reactions Weekly 1627:1, pages 153-153.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.